Vitamin D (VD) influences genetic expression through its receptor (VDR). VD pathway gene polymorphisms seem to influence antiviral drug pharmacokinetics and therapeutic outcome/toxicity. We investigated the association between daclatasvir (DCV) plasma concentrations and genetic variants (SNPs) associated with the VD pathway.
Titolo: | Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy | |
Autori Riconosciuti: | ||
Autori: | Cusato, Jessica; Nicolò, Amedeo De; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Pinna, Simone Mornese; Carcieri, Chiara; Guido, Federica; Cariti, Giuseppe; Perri, Giovanni Di; D'Avolio, Antonio | |
Data di pubblicazione: | 2018 | |
Abstract: | Vitamin D (VD) influences genetic expression through its receptor (VDR). VD pathway gene polymorphisms seem to influence antiviral drug pharmacokinetics and therapeutic outcome/toxicity. We investigated the association between daclatasvir (DCV) plasma concentrations and genetic variants (SNPs) associated with the VD pathway. | |
Volume: | 19 | |
Fascicolo: | 8 | |
Pagina iniziale: | 701 | |
Pagina finale: | 706 | |
Digital Object Identifier (DOI): | 10.2217/pgs-2018-0009 | |
Parole Chiave: | CYP24A1; DAAs; SNP; VDR; pharmacogenetics; pharmacokinetics | |
Rivista: | PHARMACOGENOMICS | |
Appare nelle tipologie: | 03A-Articolo su Rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
cusato2018.pdf | PDF EDITORIALE | Utenti riconosciuti Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.